85 related articles for article (PubMed ID: 23220852)
1. BBC3 is down-regulated with increased tumor size independently of p53 expression in head and neck cancer.
Tajnik M; Stražišar M; Volavšek M; Boštjančič E; Glavač D
Cancer Biomark; 2012; 11(5):197-208. PubMed ID: 23220852
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of neutrophil gelatinase-associated lipocalin in head and neck squamous cell carcinoma correlated with tumorigenesis, not with metastasis.
Wang L; Chen C; Li F; Hua Q; Chen S; Xiao B; Dai M; Li M; Zheng A; Yu D; Hu Z; Tao Z
Int J Clin Exp Pathol; 2015; 8(8):8857-68. PubMed ID: 26464627
[TBL] [Abstract][Full Text] [Related]
3. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
[TBL] [Abstract][Full Text] [Related]
4. Expression of apoptosis-related genes in human head and neck squamous cell carcinomas undergoing p53-mediated programmed cell death.
Frederick MJ; Holton PR; Hudson M; Wang M; Clayman GL
Clin Cancer Res; 1999 Feb; 5(2):361-9. PubMed ID: 10037186
[TBL] [Abstract][Full Text] [Related]
5. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y
Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493
[TBL] [Abstract][Full Text] [Related]
7. A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas.
Lee TL; Yeh J; Friedman J; Yan B; Yang X; Yeh NT; Van Waes C; Chen Z
Int J Cancer; 2008 May; 122(9):1987-98. PubMed ID: 18172861
[TBL] [Abstract][Full Text] [Related]
8. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous apoptosis and the expression of p53 and Bcl-2 family proteins in locally advanced head and neck cancer.
Hotz MA; Bosq J; Zbaeren P; Reed J; Schwab G; Krajewski S; Brousset P; Borner MM
Arch Otolaryngol Head Neck Surg; 1999 Apr; 125(4):417-22. PubMed ID: 10208679
[TBL] [Abstract][Full Text] [Related]
10. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
Namani A; Matiur Rahaman M; Chen M; Tang X
BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
[TBL] [Abstract][Full Text] [Related]
11. SMYD2 overexpression is associated with tumor cell proliferation and a worse outcome in human papillomavirus-unrelated nonmultiple head and neck carcinomas.
Ohtomo-Oda R; Komatsu S; Mori T; Sekine S; Hirajima S; Yoshimoto S; Kanai Y; Otsuji E; Ikeda E; Tsuda H
Hum Pathol; 2016 Mar; 49():145-55. PubMed ID: 26826421
[TBL] [Abstract][Full Text] [Related]
12. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
[TBL] [Abstract][Full Text] [Related]
13. Gene expression analysis of head and neck squamous cell carcinoma survival and recurrence.
Zhi X; Lamperska K; Golusinski P; Schork NJ; Luczewski L; Kolenda T; Golusinski W; Masternak MM
Oncotarget; 2015 Jan; 6(1):547-55. PubMed ID: 25575813
[TBL] [Abstract][Full Text] [Related]
14. Lower DSC1 expression is related to the poor differentiation and prognosis of head and neck squamous cell carcinoma (HNSCC).
Wang Y; Chen C; Wang X; Jin F; Liu Y; Liu H; Li T; Fu J
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2461-2468. PubMed ID: 27601166
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA profile in site-specific head and neck squamous cell cancer.
Kalfert D; Pesta M; Kulda V; Topolcan O; Ryska A; Celakovsky P; Laco J; Ludvikova M
Anticancer Res; 2015 Apr; 35(4):2455-63. PubMed ID: 25862914
[TBL] [Abstract][Full Text] [Related]
16. Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases.
Cortesina G; Martone T; Galeazzi E; Olivero M; De Stefani A; Bussi M; Valente G; Comoglio PM; Di Renzo MF
Int J Cancer; 2000 May; 89(3):286-92. PubMed ID: 10861506
[TBL] [Abstract][Full Text] [Related]
17. Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck.
Frank DK; Liu TJ; Frederick MJ; Clayman GL
Clin Cancer Res; 1998 Sep; 4(9):2265-72. PubMed ID: 9748148
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the chemosensitivity of head and neck cancer cells based on the diverse function of mutated-p53.
Shinagawa Y; Kawamata H; Omotehara F; Nakashiro K; Hoque MO; Furihata T; Horiuchi H; Imai Y; Fujimori T; Fujibayashi T
Int J Oncol; 2003 Feb; 22(2):383-9. PubMed ID: 12527938
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of microRNAs as markers for the detection of neck lymph node metastases in patients with head and neck squamous cell carcinoma.
de Carvalho AC; Scapulatempo-Neto C; Maia DC; Evangelista AF; Morini MA; Carvalho AL; Vettore AL
BMC Med; 2015 May; 13():108. PubMed ID: 25956054
[TBL] [Abstract][Full Text] [Related]
20. Bcl-2 but not Bax expression is associated with apoptosis in normal and transformed squamous epithelium.
Drenning SD; Marcovitch AJ; Johnson DE; Melhem MF; Tweardy DJ; Grandis JR
Clin Cancer Res; 1998 Nov; 4(11):2913-21. PubMed ID: 9829760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]